600713 logo

Nanjing Pharmaceutical Group Company Limited Stock Price

SHSE:600713 Community·CN¥7.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600713 Share Price Performance

CN¥0
-4.84 (-100.00%)
CN¥0
-4.84 (-100.00%)
Price CN¥0

600713 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Established dividend payer with mediocre balance sheet.

2 Risks
1 Reward

Nanjing Pharmaceutical Group Company Limited Key Details

CN¥53.9b

Revenue

CN¥50.6b

Cost of Revenue

CN¥3.3b

Gross Profit

CN¥2.7b

Other Expenses

CN¥530.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 11, 2026
0.41
6.08%
0.98%
157.5%
View Full Analysis

About 600713

Founded
1951
Employees
4830
CEO
Liang Zhang
WebsiteView website
www.njyy.com

Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.

Recent 600713 News & Updates

Recent updates

No updates